Commentary on "Dysfunctional dendritic cells limit antigen-specific T cell response in glioma"
Neuro Oncol
.
2023 Feb 14;25(2):277-278.
doi: 10.1093/neuonc/noac256.
Authors
Robert M Prins
1
2
3
4
,
Richard G Everson
1
3
Affiliations
1
Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
2
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
3
Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
4
Parker Institute for Cancer Immunotherapy, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
PMID:
36445342
PMCID:
PMC9925671
DOI:
10.1093/neuonc/noac256
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Brain Neoplasms*
Dendritic Cells
Glioma*
Humans
T-Lymphocytes
Grants and funding
P50 CA211015/CA/NCI NIH HHS/United States